Boelaert M
Boelaert M
Professor of Epidemiology and Control of Neglected Tropical Diseases, Institute of Tropical Medicine
Verified email at itg.be
TitleCited byYear
Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?
F Chappuis, S Sundar, A Hailu, H Ghalib, S Rijal, RW Peeling, J Alvar, ...
Nature reviews microbiology 5 (11supp), S7, 2007
14262007
Adhesion-related hospital readmissions after abdominal and pelvic surgery: a retrospective cohort study
H Ellis, BJ Moran, JN Thompson, MC Parker, MS Wilson, D Menzies, ...
The Lancet 353 (9163), 1476-1480, 1999
9341999
Effect of spiritual well-being on end-of-life despair in terminally-ill cancer patients
CS McClain, B Rosenfeld, W Breitbart
The lancet 361 (9369), 1603-1607, 2003
9012003
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda
PJ Guerin, P Olliaro, S Sundar, M Boelaert, SL Croft, P Desjeux, ...
The Lancet infectious diseases 2 (8), 494-501, 2002
8682002
Leishmaniasis: public health aspects and control
P Desjeux
Clinics in dermatology 14 (5), 417-423, 1996
7981996
Spread of vector-borne diseases and neglect of Leishmaniasis, Europe
JC Dujardin, L Campino, C Cañavate, JP Dedet, L Gradoni, K Soteriadou, ...
Emerging infectious diseases 14 (7), 1013, 2008
3702008
Control of visceral leishmaniasis in Latin America—a systematic review
GAS Romero, M Boelaert
PLoS neglected tropical diseases 4 (1), e584, 2010
3442010
Kashin–Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status
R Moreno-Reyes, C Suetens, F Mathieu, F Begaux, D Zhu, MT Rivera, ...
New England Journal of Medicine 339 (16), 1112-1120, 1998
3261998
Liposomal amphotericin B for the treatment of visceral leishmaniasis
LD Saravolatz, C Bern, J Adler-Moore, J Berenguer, M Boelaert, ...
Clinical Infectious Diseases 43 (7), 917-924, 2006
2962006
Refugee health
MS Frontières
An Approach to emergency situations, 1997
2681997
A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis
F Chappuis, S Rijal, A Soto, J Menten, M Boelaert
Bmj 333 (7571), 723, 2006
2652006
Combination therapy for visceral leishmaniasis
J van Griensven, M Balasegaram, F Meheus, J Alvar, L Lynen, M Boelaert
The Lancet infectious diseases 10 (3), 184-194, 2010
2562010
Recurrence in tuberculosis: relapse or reinfection?
ML Lambert, E Hasker, A Van Deun, D Roberfroid, M Boelaert, ...
The Lancet infectious diseases 3 (5), 282-287, 2003
2292003
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance
S Rijal, B Ostyn, S Uranw, K Rai, NR Bhattarai, TPC Dorlo, JH Beijnen, ...
Clinical Infectious Diseases 56 (11), 1530-1538, 2013
2152013
Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use
S Sundar, A Singh, M Rai, VK Prajapati, AK Singh, B Ostyn, M Boelaert, ...
Clinical infectious diseases 55 (4), 543-550, 2012
2052012
Diagnostic tests for kala-azar: a multi-centre study of the freeze-dried DAT, rK39 strip test and KAtex in East Africa and the Indian subcontinent
M Boelaert, S El-Safi, A Hailu, M Mukhtar, S Rijal, S Sundar, M Wasunna, ...
Transactions of the Royal Society of Tropical Medicine and Hygiene 102 (1 …, 2008
1682008
Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy
R Moreno-Reyes, F Mathieu, M Boelaert, F Begaux, C Suetens, ...
The American journal of clinical nutrition 78 (1), 137-144, 2003
1612003
A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis
M Boelaert, S Rijal, S Regmi, R Singh, B Karki, D Jacquet, F Chappuis, ...
The American journal of tropical medicine and hygiene 70 (1), 72-77, 2004
1592004
The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India
M Boelaert, F Meheus, A Sanchez, SP Singh, V Vanlerberghe, A Picado, ...
Tropical medicine & international health 14 (6), 639-644, 2009
1412009
Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru
A Llanos-Cuentas, G Tulliano, R Araujo-Castillo, C Miranda-Verastegui, ...
Clinical Infectious Diseases 46 (2), 223-231, 2008
1412008
The system can't perform the operation now. Try again later.
Articles 1–20